Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires
Patient-identified barriers to asthma treatment adherence: responses to interviews, focus groups, and questionnaires
复制标题
DOI：
10.1016/j.iac.2004.09.005
复制
发表时间：
2005-02-01
影响因子：
2.6
通讯作者：
Bender, SE
中科院分区：
文献类型：
--
作者：
Bender, BG;Bender, SE
本文回顾了32项患者访谈研究，这些研究调查了患者发现的最常见的依从性障碍，包括对药物安全性和成本的担忧以及患者哮喘不严重到需要每日治疗的信念。重要但不太常见的担忧包括担心长期使用药物会产生依赖性或降低有效性。儿童及其父母对安全依赖、同伴污名化和父母与孩子之间的冲突表示担忧。低收入和少数族裔患者也提到了类似的担忧和障碍，包括费用、难以获得药物、日常生活麻烦以及对医疗机构的普遍不信任。从患者的角度获得的信息表明，需要重新评估目前的哮喘管理策略，包括更灵活的方法来使用专家指南治疗哮喘。
This article reviews 32 patient-interview studies that surveyed the most common barriers to adherence revealed by patients included concerns about drug safety and cost and a belief that the patient's asthma was not severe enough to require daily treatment. Important but less commonly cited concerns included worry about dependence or diminished effectiveness with long-term use of the medication. Children and their parents expressed concerns about safety dependence, peer stigmatization, and parent-child conflict over taking medication. Low-income and minority patients cited similar concerns and barriers that included cost, difficulty of obtaining medication, daily life hassles, and a general distrust of the medical establishment. The information obtained from patients' perspectives indicates the need to reappraise current strategies for the management of asthma, including a more flexible approach to the use of expert guidelines for the treatment of asthma.